TheProfitWatch

ONCO - Onconetix, Inc. Common Stock

Day 1m 10m 60m PreMarket Market AfterHours Gap
3.7 -0.17 (-4.59%) --- --- --- -0.18 (-4.86%) -0.1 (-2.83%) -0.03 (-0.84%) -0.03 (-0.84%)

Onconetix Inc is a commercial-stage biotechnology company focused on the research, development, and commercialization of solutions for men's health and oncology. It has a product named Entadfi an FDA-approved once-daily oral therapeutic for the treatment of benign prostatic hyperplasia, a disorder of the prostate, along with building additional assets in therapeutics, diagnostics, and clinician services for oncology.

Category: PHARMACEUTICAL PREPARATIONS
Market Period: Closed

Earnings & Ratios

Basic EPS:
-4.76
Diluted EPS:
-4.76
Basic P/E:
-0.7416
Diluted P/E:
-0.7416
RSI(14) 1m:
100.0
VWAP:
3.53
RVol:

Events

Period Kind Movement Occurred At

Related News